{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-086313","form_type":"8-K","ticker":"UHS","cik":"0000352915","company_name":"UNIVERSAL HEALTH SERVICES INC","filed_at":"2024-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.506515+00:00","generated_at":"2026-05-31T16:25:59.868030+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"UHS Q2 EPS $4.26 vs $2.42 YoY; raises 2024 guidance; adds $1B to buyback","bullets":["Q2 net income $289.2M ($4.26 diluted EPS) vs $171.3M ($2.42) YoY; adjusted EPS $4.31.","Net revenues $3.908B (+10.1% YoY); same-facility acute revenue +6.6%, behavioral +11.0%.","Revised 2024 guidance: Adj. EPS $15.40-$16.20 (prev $13.00-$14.00); Adj. EBITDA $2.154B-$2.226B (prev $1.931B-$2.019B).","Board authorizes $1B increase to stock repurchase program; total authorization now $1.228B.","Operating cash flow $1.076B through June 2024 vs $654M in 2023, up 64%."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-086313","json":"https://secwatch.observer/filing/0000950170-24-086313.json","markdown":"https://secwatch.observer/filing/0000950170-24-086313.md","text":"https://secwatch.observer/filing/0000950170-24-086313.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/352915/000095017024086313/0000950170-24-086313-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/352915/000095017024086313/uhs-20240724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T16:25:59.868030+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}